Silver Coatings in Reconstructive Orthopaedics: Basic Science and Clinical Rationale.


Journal

Surgical technology international
ISSN: 1090-3941
Titre abrégé: Surg Technol Int
Pays: United States
ID NLM: 9604509

Informations de publication

Date de publication:
23 11 2021
Historique:
pubmed: 25 11 2021
medline: 15 12 2021
entrez: 24 11 2021
Statut: ppublish

Résumé

Prosthetic joint infection (PJI) is one of the most devastating complications that can occur following total hip and total knee arthroplasty. Despite the remarkable advances that have been made in surgical techniques and implant technology, the incidence of PJI has remained largely unchanged over the past two decades. One approach that has been described in the literature to minimize the risk of PJI has been the use of silver-coated prostheses. Silver has been reported to have antimicrobial properties when added to a variety of orthopaedic materials including bone cement, hydroxyapatite coatings and wound dressings. Silver is also being increasingly used as a surface coating for endoprostheses used for reconstruction around the hip and the knee with the specific aim of reducing the incidence of prosthetic joint infection. Despite the increasing adoption of this technology, the use of silver coatings remains controversial. The optimal method for preparation and the thickness of the coating, as well as the mechanism(s) of action in reducing the incidence of PJI, are unclear. The issue of silver toxicity is also an important consideration. This paper provides an overview of the use of silver coatings in reconstructive orthopaedics, as well as the types available and techniques used to coat endoprostheses. We also review the basic science as well as the clinical applications of silver coatings in the prevention of PJIs.

Identifiants

pubmed: 34816419
pii: sti39/1500
doi:

Substances chimiques

Silver 3M4G523W1G

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

413-417

Auteurs

Bryce N Clinger (BN)

Department of Orthopaedic Surgery, University of New Mexico School of Medicine, Albuquerque, NM, USA.

Helmut D Link (HD)

Waldemar Link GmbH, Germany.

Dustin L Richter (DL)

Department of Orthopaedic Surgery, University of New Mexico School of Medicine, Albuquerque, NM, USA.

Daniel Kendoff (D)

Helios EndoKlinik, Hamburg, Germany.

Mustafa Citak (M)

Helios EndoKlinik, Hamburg, Germany.

Nemandra Amir Sandiford (NA)

Joint Reconstruction Unit, Southland Teaching Hospital, Invercargill, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH